NeuroPace (NPCE) Shares Outstanding (Weighted Average) (2020 - 2026)

NeuroPace's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $33.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7.1% year-over-year to $33.7 million; the TTM figure through Mar 2026 stood at $33.7 million (up 7.1% YoY), while the FY2025 annual figure was $32.7 million, up 12.35% from the prior year.
• Shares Outstanding (Weighted Average) was $33.7 million for Q1 2026 at NeuroPace, up from $32.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $33.7 million in Q1 2026 to a low of $24.3 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $28.2 million across 5 years, with a median of $28.3 million in 2024.
• Biggest YoY gain for Shares Outstanding (Weighted Average) was 8930.26% in 2022; the steepest drop was 2.6% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $24.6 million in 2022, then grew by 5.11% to $25.9 million in 2023, then increased by 12.67% to $29.1 million in 2024, then advanced by 12.35% to $32.7 million in 2025, then climbed by 3.04% to $33.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $33.7 million (Q1 2026), $32.7 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.